NeuPath Health Inc.
NPTH.V
TSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.15% | 4.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.15% | 4.85% | |||
| Cost of Revenue | 0.31% | 3.71% | |||
| Gross Profit | -2.11% | 9.96% | |||
| SG&A Expenses | -8.21% | 7.48% | |||
| Depreciation & Amortization | -0.98% | -0.36% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.99% | 4.11% | |||
| Operating Income | 53.51% | 92.99% | |||
| Income Before Tax | -32.29% | 48.57% | |||
| Income Tax Expenses | 251.14% | -30.71% | |||
| Earnings from Continuing Operations | -77.14% | 45.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -29.09% | 18.88% | |||
| Net Income | -64.46% | 40.48% | |||
| EBIT | 53.51% | 92.99% | |||
| EBITDA | 88.87% | -26.58% | |||
| EPS Basic | -64.52% | 40.38% | |||
| Normalized Basic EPS | 166.67% | 83.33% | |||
| EPS Diluted | -125.81% | 57.53% | |||
| Normalized Diluted EPS | 166.67% | 83.33% | |||
| Average Basic Shares Outstanding | -0.32% | 0.01% | |||
| Average Diluted Shares Outstanding | 1.39% | -0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||